Helminth Infection and Eosinophilia and the Risk of Plasmodium falciparum Malaria in 1- to 6-Year-Old Children in a Malaria Endemic Area by Bejon, Philip et al.
Helminth Infection and Eosinophilia and the Risk of
Plasmodium falciparum Malaria in 1- to 6-Year-Old
Children in a Malaria Endemic Area
Philip Bejon
1,2*, Tabitha W. Mwangi
1, Brett Lowe
1, Norbert Peshu
1, Adrian V. S. Hill
2,3, Kevin Marsh
1,4
1Kenya Medical Research Institute, Centre for Geographical Medicine Research (Coast), Kilifi, Kenya, 2Centre for Clinical Vaccinology and Tropical Medicine, University of
Oxford, Oxford, United Kingdom, 3Wellcome Trust Centre for Human Genetics, University of Oxford, Oxford, United Kingdom, 4Nuffield Department of Clinical Medicine,
Oxford University, John Radcliffe Hospital, Oxford, United Kingdom
Abstract
Background: Helminth infection is common in malaria endemic areas, and an interaction between the two would be of
considerable public health importance. Animal models suggest that helminth infections may increase susceptibility to
malaria, but epidemiological data has been limited and contradictory.
Methodology/Principal Findings: In a vaccine trial, we studied 387 one- to six-year-old children for the effect of helminth
infections on febrile Plasmodium falciparum malaria episodes. Gastrointestinal helminth infection and eosinophilia were
prevalent (25% and 50% respectively), but did not influence susceptibility to malaria. Hazard ratios were 1 for
gastrointestinal helminth infection (95% CI 0.6–1.6) and 0.85 and 0.85 for mild and marked eosinophilia, respectively (95% CI
0.56–1.76 and 0.69–1.96). Incident rate ratios for multiple episodes were 0.83 for gastro-intestinal helminth infection (95% CI
0.5–1.33) and 0.86 and 0.98 for mild and marked eosinophilia (95% CI 0.5–1.4 and 0.6–1.5).
Conclusions/Significance: There was no evidence that infection with gastrointestinal helminths or urinary schistosomiasis
increased susceptibility to Plasmodium falciparum malaria in this study. Larger studies including populations with a greater
prevalence of helminth infection should be undertaken.
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Introduction
Helminth and malaria endemic areas frequently coincide, and an
interaction between the two would be of considerable public health
importance [1,2]. Animal models suggest that helminth infections
may alter susceptibility to malaria, although the results are conflicting
[3,4]. In studies conducted among malaria endemic populations in
Africa, helminths have been reported to increase susceptibility to
clinical malaria [5,6], reduce the risk [7] or make no difference [8].
Studies in Thailand suggest helminths might increase the risk of non-
severe malaria, but reduce the risk of cerebral malaria [9,10].
The Th2 cytokine milieu induced by helminth infection is
thought to drive the antibody response of malaria co-infected
individuals towards the production of non-cytophilic subclasses
(IgG2, IgG4, and IgM), whereas protection against malaria is
associated with the presence of the IgG1 and IgG3 cytophilic
subclasses [11]. The cytokine milieu could also favour either pro-
or anti- inflammatory reactions during malaria infection [12].
We recently conducted a randomized controlled trial of a T cell
inducing vaccine in a malaria endemic area. 387 immunised
children were monitored for episodes of malaria for 9 months after
receiving either an experimental T cell inducing vaccine or a
control (rabies) vaccination [13]. Since helminth infection might
be a covariate for risk of febrile malaria, and might interfere with
vaccine efficacy [11], we prospectively obtained stool and urine
samples for microscopy on all children enrolled into the trial, and
measured peripheral eosinophilia. Here, we study the effect of
helminth co-infections on the incidence of malaria.
Methods
Study participants
405 children, aged 1 to 6 years (inclusive), were randomized for
either an experimental prime boost malaria vaccine or control
vaccination (rabies). The trial was assigned registration number
ISRCTN88335123 with the International Standard Randomized
Controlled Trial Number Register (http://www.controlled-trials.
com/isrctn/trial/|/0/88335123.html). The study was performed
with the permission of KEMRI National Ethics Committees, and
COREC, the NHS Central Office for Research Ethics Committees.
The children were healthy, and resident in the study area. The study
area was limited to Junju sub-location in Kilifi district, Kenya. The
entomological inoculation rate (EIR) is 22–53 infective bites/
person/year [14]. Malaria transmission continues all year, with
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detailed elsewhere [13]. Of these 405 children, follow-up visits were
completed for 387 children, among whom 122 children had one or
more episodes of Plasmodium falciparum malaria. Treatment with
mebendazole and praziquantel was available in local dispensaries,
but drug use was monitored among the study participants for the
duration of the study by locally-based field workers.
Samples
Eosinophilia was measured in blood taken one week post-
vaccination (early May 2005). Single urine and stool specimens
collected for microscopy in January 2006. Full blood counts were
successfully analysed on 347 of the 387 children, and stool and
urine samples collected for 315 and 294 children, respectively.
Monitoring for malaria episodes
Children were seen weekly by field workers, and blood films
made when the temperature was $37.5uC. Field workers lived in
the study area, and parents brought their children for assessment
between regular weekly visits if the child developed fever.
Treatment for episodes of malaria was with the Government of
Kenya recommended first line treatment, artemether-lumefan-
trine. In analysis, a threshold of 2,500 asexual parasites of P
falciparum per ml was used to determine febrile malaria. This
threshold was derived in previous studies in Kilifi for use in
children above one year of age [15].
Laboratory procedures
Blood films were examined in duplicate by two microscopists,
and examined a third time if there was a discrepancy. Eosinophil
counts were measured by a COULTERH Ac?T
TM 5diff CP. Wet
microscopy was conducted on mid-morning terminal urine
samples and stool.
Children who were positive for schistosomiasis or gastrointes-
tinal helminth infection were given praziquantel (40 mg per kg) or
mebendazole (100mg twice daily for 3 days), respectively.
Vaccination was complete by day 90, and treatment was given
on day 150. All analysis is conducted on pre-treatment data.
Analysis
The primary analysis was a log rank test comparing the
time to the first or only episode of malaria between worm
infected and uninfected children (unadjusted). The hazard ratio
and 95% confidence interval was also estimated by Cox’s
regression, adjusted for age group, ITN (insecticide treated net)
use and village. Age group was a categorical variable with
three levels (1–2 years old, 2–5 years old, 5–6 years old).
Village had 5 levels. ITN use was defined as sleeping every
night under a treated net, which had less than three holes into
which a finger could comfortably fit. The vaccination was not
efficacious [13], and since adjusting for vaccine allocation
made no difference to the results, the analysis presented here is
unadjusted.
Poisson regression was used to estimate the incidence rate ratio
taking into account all malaria episodes, adjusted for the same
covariates. A period of 28 days after each malaria episode was
deducted from the person time at risk.
Results
Gastrointestinal helminth infection
Stool samples were examined from 326 children. 25% were
positive for ova indicating gastrointestinal worm infection. The
three most common infections were Ascaris lumbricoides (18%),
Trichuris trichiura (4.5%) and hookworm ova (3%).
The Kaplan Meier (KM) plot (Figure 1) of clinical malaria
episodes (fever $37.5uC and parasitaemia .2,500 per ml) shows
similar rates for children with and without gastro-intestinal
helminth infections (p=0.98). Children with positive stool samples
were treated soon after day 150 with mebendazole.
Further modelling of the hazard and of multiple episodes
(Figure 2) excluded the period after treatment. In a Cox
regression model, adjusted for age, village and ITN use, the
modelled hazard ratio (HR) for first episode of malaria was 1.01
(95% CI 0.64–1.57, p=0.98). In a Poisson regression model for
the number of malaria episodes, the incidence rate ratio (IRR)
was 0.83 (95% CI 0.51–1.33, p=0.45). The risk associated with
A. lumbricoides infection alone was also considered. The HR for
first episode of malaria was 0.65 (95% CI 0.39–1.25, p=0.23)
and in Poisson regression, the IRR was 0.67 (95% CI 0.37–1.2,
p=0.18).
Urinary schistosomiasis
Urine samples were examined from 294 children. Only 24
children (8%) had eggs of Schistosoma haematobium in urine, as
identified by microscopy. The confidence intervals of estimates of
clinical malaria risk among children with urinary schistosomiasis
are therefore wide, and so data on the survival function is not
shown in detail. The adjusted HR was 0.55 (95% CI 0.23–1.38,
p=0.8) and the IRR was 0.69 (95% CI 0.28–1.73, p=0.2. This is
shown in Figure 2. Schistosomiasis and gastrointestinal helminth
infection were not associated (x=0.53, p=0.46) and only 7
children had dual infections.
Eosinophilia
Eosinophil counts were available from 347 children. 19% had
highly elevated counts (.1610
6/ml) and 31% had mildly elevated
counts (.0.5610
6/ml). Peripheral blood eosinophil counts were
conducted as a more sensitive marker of parasitic infection than
microscopy. Neither Kaplan Meier plots (Figure 1, p=0.71) nor
adjusted estimates of risk (Figure 2) showed significant variations in
malaria episodes by eosinophil count. Mild eosinophilia was
associated with a HR of 0.85 (95% CI 0.51–1.43, p=0.55) and an
IRR of 0.86 (95% CI 0.51–1.4, p=0.6). High eosinophilia was
associated with a HR=0.85 (95% CI 0.69–1.96, p=0.47) and an
IRR of 0.98 (95% CI 0.63–1.5, p=0.57).
Author Summary
Malaria infection and other parasitic infections are
widespread in developing countries. There is evidence
from some studies that intestinal worm infections may
increase the risk of developing febrile malaria. However,
the evidence is mixed, and some studies have found no
effect or even protective effects. A vaccine trial was
recently conducted to assess the efficacy of a candidate
malaria vaccine. Episodes of malaria were monitored. The
vaccine was not protective, but data was also recorded on
the prevalence of worm infections. The rates of febrile
malaria did not seem to vary according to worm infection
in this study. However, because of the relatively low
prevalence of worm infection, the study did not have high
power. Given the conflicting findings in the literature, and
the potential for the effect of worm infection to vary
geographically, it is important that larger, definitive studies
are conducted, since even quite small effects might be
important for global public health.
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are given below the Kaplan Meier plots. Both plots use an endpoint of .2,500 parasites per microlitre and fever. Plot a) compares the probability of
remaining free of clinical malaria for children with gastrointestinal helminth infection (GI Helm.) and uninfected children. Plot b) compares the
probability of remaining free of clinical malaria for children with normal eosinophil counts (below 0.5610
6 per ml), mild eosinophilia (0.5–1610
6/ml)
or high eosinophilia (above 1610
6/ml). The survival curves are not significantly different by unadjusted log-rank testing (p=0.98 for gastrointestinal
worm infection, p=0.71 for eosinophilia).
doi:10.1371/journal.pntd.0000164.g001
Figure 2. The coefficients from cox regression models (left) and the coefficients from poisson regression models (right) adjusted
for the same covariates are displayed for the effect of gastrointestinal helminth infection (GI Hel), A. lumbricoides infection (A. l.), S.
haematobium (Sch), mild eosinophilia (Mild Eos) and marked eosinophilia (High Eos), adjusted for age, village and ITN use.
doi:10.1371/journal.pntd.0000164.g002
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Schistosomiasis was seen in 0% of 1–2 year olds, 8% of 2–
5 year olds and 14% of 5–7 year olds (p=0.02), and gastrointes-
tinal worm infections were seen in 11% of 1–2 year old, 25% of 2–
5 year olds and 36% of 5–7 year olds (p=0.003). Interestingly,
eosinophilia became less frequent with age, from 63% of 1–2 year
olds to 50% of 2–5 year olds and 42% of 5–7 year olds (p=0.03).
Anaemia and helminth infections
The average haemoglobin among children with gastrointestinal
helminth infection was 10.47 g/dl (95% CI 10.2–10.8) and
10.21 g/dl (95% CI 10–10.4) among uninfected children,
p=0.23. For children with schistovuria the average haemoglobin
was 10.83 g/dl (95% CI 10.3–11.4) and 10.33 g/dl (95% CI 10.1–
10.5) among uninfected children, p=0.16.
Discussion
The data presented here were acquired during a trial designed
primarily to examine vaccine efficacy. Children with gastrointes-
tinal parasites or urinary schistosomiasis were treated with
mebendazole or praziquantel, respectively. However, treatment
was delayed for 150 days after screening, and the majority of
malaria episodes (25% of children) occurred before the children
were treated. Only 6% of children had a malaria episode after
treatment (which coincided with the end of the high transmission
season). We did not identify altered susceptibility to malaria
associated with helminth infection, determined either by direct
microscopy or inferred by peripheral eosinophilia.
There were similar findings in Uganda [8] where soil-
transmitted helminths were not associated with an increased risk
of febrile malaria. In Senegal, other cohort studies have suggested
that schistosomiasis increases the risk of febrile malaria [6], and
hospital-based case-control studies suggest both schistosomiasis
and A. lumbricoides infection are risk factors for hospital admission
with malaria [16]. However, a cohort study in Mali using weekly
surveillance suggested that schistosome infection may actually
protect from malaria [7]. Other studies suggesting that helminth
infection might be protective relate to Thai adults, conducted by a
group using case-control studies to examine severe disease [9,17–
19]. However, this group also conducted one cohort study
examining febrile disease, where susceptibility was conferred by
intestinal helminth infection [20]. Recent reviews of the evidence
appear to focus on the possibility that helminth infection might
increase susceptibility to malaria [1,2,11]. Of the cohort studies,
the sample sizes were 80 [5], 511 [6], 654 [7] and 435 [8]. The
prevalence of helminth infection was 16% [5], 67% [6], 25% [7]
and 17–47% [8]. Our study with 387 children, and prevalence of
25%, 50% and 8% for intestinal infection, eosinophilia and
schistosomiasis, respectively, is therefore quite comparable in
terms of power.
Microscopy was only performed on a single specimen in our
study, and we did not use concentration techniques. This would
have missed lighter infections. This misclassification may have
introduced bias against detecting an association. In previous
studies that identified an increased risk of malaria in schistosome-
infected children, multiple specimens were examined, although the
greatest increase in risk was associated with heavier infections [6],
which are not likely to have been missed by a single examination.
Studies that report a positive association with soil-transmitted
helminths did not depend on examining multiple specimens
[5,16], and even in a low prevalence area with light infections, the
yield from repeated examinations is low [21]. The use of
artesunate further complicates our assessment. This appears to
result in a reduction in a relatively rapid reduction in egg
production among infected children [22], and it is unclear how
rapidly this might alter host susceptibility to malaria. Our primary
analysis of gastrointestinal infection did not differentiate on the
basis of species, but secondary analysis that was restricted to A.
lumbricoides infection did not show a tendency towards increased
risk of malaria in infected children either.
The low prevalence of helminth infection limits the power of the
study, but by how much? This can be judged by the confidence
intervals associated with the estimates of efficacy, from power
calculations, and from inspecting the KM plots. The CIs around
the estimates of risk are narrower than a halving or doubling of
risk in each analysis conducted. The narrowest CIs are those
derived for all gastrointestinal helminth infections and eosinophil-
ia, followed by A. lumbricoides infection alone, with CIs for
Schistosoma haematobium the widest. The tendency is in the direction
of decreased rather than increased susceptibility, so the possible
increases in risk that could have been missed are not large for
gastrointestinal helminth infections and eosinophilia, but quite
large effects of schistosome infection might have been missed. The
primary analysis was log rank testing of time to event. Assuming a
constant effect over time, with the prevalence of gastrointestinal
helminth infection at 25%, then a log rank analysis had 80%
power to detect a 70% increase or 50% decrease in risk due to
helminth infection. Power was very low for schistosomiasis, with
80% power to detect a 110% increase or 90% decrease, but 80%
power to detect an 80% increase or 60% decrease for A.
lumbricoides infection alone. However, as it turned out, the upper
limits of the confidence intervals measured suggest that 60–80%
increases in risk are unlikely, although greater decreases in risk
have not been ruled out. Previous studies have suggested a
doubling in risk of febrile malaria in schistosome-infected children
[6], and 64% from soil-transmitted helminths [5]. The increased
risk seen secondary to schistosomiasis was seen only in the heavily
infected children, and our study did not differentiate heavy from
light infections.
On inspection of the KM plots, there is no marked separation of
the helminth-infected and uninfected at any stage. Between 50 and
125 days, helminth-infected children have acquired slightly fewer
cases of febrile malaria, but this difference is slight, and the lines
converge by 150 days. After 150 days there is a slight reduction in
the number of children with febrile malaria among those with
moderate and high eosinophil counts. This suggests that further
studies to examine the impact of helminth infection in this
population would need to be considerably larger.
The results of individual studies may be dependant on the
transmission intensity of both worm and Plasmoidium infections.
In our study, the moderately high malaria transmission meant that
significant immunity had been acquired by children aged 5–7
compared with 1–2 year olds (HR 0.24, 95% CI 0.1–0.54,
p=0.001). However, worm infection is more frequent in the older
age groups, and the interaction between worms and malaria may
depend critically on being exposed to helminth infections while
immunity to malaria is being acquired. We did not measure
intensity of infection in this study, and it is possible that among
older children, with more intense worm infections, there might
have been a relationship between helminth infection and malaria.
However, these children would have a low incidence of malaria.
Previous studies identifying increased susceptibility to malaria
among helminth infection have been conducted in settings of more
prevalent helminth infection.
50% of children had either mild or high eosinophilia, compared
with a prevalence of 7% for urinary schistosomiasis and 25% for
gastrointestinal helminth infection. The higher prevalence may
Helminth Infections and Malaria Risk
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filarial infection (which we did not examine for). Strongyloides
stercoralis infection is also associated with eosinophilia, and would
not have been identified by the stool examination conducted in
this study. Eosinophilia is closely associated with the TH2 cytokine
responses which might result in the increased susceptibility to
malaria [23], and might therefore have been expected to be a
more discriminatory marker. Eosinophilia was not associated with
altered rates of malaria in this study. However, the potentially
deleterious responses that can be induced by helminths include
TH1 and regulatory responses, of which eosinophilia would not be
a marker. We found that eosinophilia became less prevalent with
age, despite the prevalence of helminth infection rising, suggesting
that eosinophilia becomes suppressed with chronic helminth
infection. As well as immunological mechanisms [24,25], it has
been hypothesised that helminth induced anaemia induces
susceptibility to malaria [24], although other data suggest that
iron deficiency protects against malaria [26]. In any case, helminth
infected children in our study were not significantly more anaemic.
This study suggests that in a cohort of one to six year old
children in a moderately high malaria transmission area are not at
increased risk of malaria from concurrent helminth infection, as
evidenced either by microscopy or by eosinophilia. In our study,
the prevalence on helminth infection was relatively low, and heavy
infections were probably infrequent. This reflects the age of the
children enrolled. However, it would not have been practical to
study older children at this transmission intensity, since immunity
against febrile disease is acquired rapidly (the HR among five to six
year old children was 0.29 (95% CI 0.15–0.58). In areas with
lower malaria transmission, older children may retain susceptibil-
ity to malaria.
What further studies should be conducted? An interaction
between helminth infection and malaria is of considerable public
health importance. If present only at lower transmission intensities,
this would still account for a very significant number of infections
globally [27], and even a slight impact on high transmission areas
might still be significant [2]. That we have not identified an effect
in the present study does not exclude a significant effect, given the
caveats associated with the methodology and sample size. Further
studies will need more detailed assessments of individual children
as well as a greater sample size. To overcome the caveats identified
in this study, multiple examinations of quantified stool specimens
will be required during the period of follow-up, multiple
geographical areas and a wider age group should be included,
and attention should be given to filarial infection, Strongyloides
stercoralis and eosinophilia. Only a large and detailed study of this
nature will satisfy concerns about multiple infections, changing
infection status of individual children, and increased susceptibility
depending critically on worm burden and age of acquisition of
immunity to malaria.
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